Business Standard

Colgate: Q4 shows non-Covid pain still high, market share recovery may drag

Down-trading, competitive intensity key concerns

Colgate
Premium

Post results on Thursday, the stock fell 1.3 per cent to Rs 1,334, and is currently trading at 41 times its FY21 estimated earnings.

Shreepad S Aute
The Covid-19-led lockdown has spared none, not even the personal care segment in the fast -moving consumer goods (FMCG) space. However, Colgate's March 2020 quarter (Q4) numbers, reported on Thursday, were not only below expectations, but analysts say pain for the toothpaste leader is not limited to Covid-19, and could remain.

Analysts believe that Colgate’s market share recovery could be delayed, despite the current situation offering a good opportunity to gain share, mainly from smaller/local players. Colgate’s market share loss has been a key worry for investors since the past few years. While the firm does not provide market share data,

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in